Most Comprehensive Molecular Profile of Indian Honeybee Venom Reveals 114 Proteins and 159 Small Molecules | Research

The takeaway

Advanced mass spectrometry identified 114 high-molecular-weight compounds (69 protein families) and 159 small molecules in Apis cerana indica honeybee venom, with Major Royal Jelly Proteins dominating the protein content.

114 proteins across 69 families
Dual mass spectrometry analysis of Indian honeybee venom identified 114 high-molecular-weight compounds spanning 69 protein families — the most comprehensive molecular profile of A. cerana indica venom to date.

What the researchers found

Using dual mass spectrometry approaches on electrically extracted Apis cerana indica venom:

**High-molecular-weight compounds:**

- 114 compounds identified across 69 protein families

- Major Royal Jelly Proteins (MRJPs) were the most dominant family: MRJPs 1-7 all detected

- MRJP 1 had the highest peptide match scores and spectrum matches among all venom proteins

**Low-molecular-weight compounds:**

- 159 total compounds detected

- 136 metabolite compounds, dominated by fatty acid derivatives (42.05%)

- 23 volatile compounds, dominated by alcohols (58.16%)

The study represents a substantial expansion of the known composition of A. cerana indica venom.

Why it matters

Honeybee venom has been used in traditional medicine for centuries and contains several compounds being investigated for modern therapeutics — including melittin (anti-cancer), apamin (neurological applications), and adolapin (anti-inflammatory). By comprehensively cataloging the composition of A. cerana indica venom, this study identifies the full repertoire of potentially bioactive compounds available for drug development. The unexpected dominance of Major Royal Jelly Proteins is particularly notable.

How the study worked

Venom was extracted from Apis cerana indica honeybees using electrical stimulation. Two untargeted mass spectrometry approaches were combined for maximum compound coverage: Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) for high-molecular-weight proteins and peptides, and Gas Chromatography-Tandem Mass Spectrometry (GC-MS/MS) for low-molecular-weight metabolites and volatile compounds.

What this study cannot tell us

This is a descriptive proteomics study — no biological activities of the identified compounds were tested. The study used untargeted approaches, so quantification is relative rather than absolute. The unexpected dominance of MRJPs may reflect contamination from the bee's body during extraction. The venom was from a single collection, and composition may vary by season, diet, or colony. No comparison with A. mellifera venom was performed. Individual peptide sequences and their potential therapeutic activities were not characterized.

How to read the evidence

This is a descriptive analytical chemistry study using advanced mass spectrometry to catalog venom composition. While it provides an important molecular inventory, no biological activities were assessed. It serves as a foundation for future functional studies rather than providing therapeutic evidence.

When this study was published

Published in 2025, this study is very recent and uses state-of-the-art dual mass spectrometry techniques to provide the most comprehensive A. cerana indica venom profile available.

The bigger picture

Venom-derived peptides are an increasingly important source of drug candidates. Honeybee venom peptides like melittin and apamin have shown promise in cancer, pain, and neurological research. However, most venom research has focused on Apis mellifera (European honeybee). This study provides the first comprehensive molecular profile of A. cerana indica (Indian honeybee) venom, which may contain unique or differently abundant bioactive compounds due to evolutionary divergence from other honeybee species.

Questions still open

Why do Major Royal Jelly Proteins dominate A. cerana indica venom — is this biologically meaningful or an extraction artifact?
Which of the 114 identified proteins have therapeutic potential, and how do they compare to the better-studied A. mellifera venom components?
Could A. cerana indica venom contain unique bioactive peptides not found in European honeybee venom?

Common questions

What makes honeybee venom useful for medicine?

Honeybee venom is a complex cocktail of proteins, peptides, and small molecules, some of which have medicinal properties. Melittin has anti-cancer and antimicrobial effects, apamin affects nerve signaling, and adolapin reduces inflammation. This study found 114 different proteins in Indian honeybee venom — far more diverse than previously known — suggesting there may be many more therapeutically useful compounds still to be discovered and characterized.

Is Indian honeybee venom different from regular honeybee venom?

Yes, potentially. This study profiled venom from Apis cerana indica (the Indian honeybee), which is a different species from Apis mellifera (the European honeybee) that most venom research focuses on. While they share many venom components, evolutionary differences mean their venoms likely differ in the exact types and amounts of proteins and peptides they contain. This study provides the most detailed catalog yet of what's in Indian honeybee venom, which could reveal unique therapeutic compounds.

Read the original research

Comprehensive profiling of Apis cerana indica Fabricius crude venom: A dual approach using LCMS and GCMS.

Toxicon : official journal of the International Society on Toxinology, 266, 108547

View on PubMed ↗Publisher’s paper ↗

Citation

Vikaash, Muthuraja; Kanagarajan, Rasappan; Manikandan, Eswaramoorthy; Dharani, Venkatraman. (2025). Comprehensive profiling of Apis cerana indica Fabricius crude venom: A dual approach using LCMS and GCMS.. Toxicon : official journal of the International Society on Toxinology, 266, 108547. https://doi.org/10.1016/j.toxicon.2025.108547